当前位置:首页 - 行情中心 - 迈克生物(300463) - 财务分析 - 现金流量表

迈克生物

(300463)

  

流通市值:45.72亿  总市值:56.23亿
流通股本:4.92亿   总股本:6.05亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,216,827,730.88614,790,809.312,786,004,053.321,957,051,919.13
  收到的税费返还25,876,260.112,964,337.5714,608,182.514,789,110.74
  收到其他与经营活动有关的现金17,883,859.399,816,681.5625,739,036.3219,907,481.77
  经营活动现金流入小计1,260,587,850.37637,571,828.442,826,351,272.141,991,748,511.64
  购买商品、接受劳务支付的现金473,924,193.71228,767,179.331,058,968,334.7702,540,113.43
  支付给职工以及为职工支付的现金305,560,157.97166,070,804.33548,123,603.95458,965,074.75
  支付的各项税费26,892,719.757,110,995.4232,090,881.17222,025,092.65
  支付其他与经营活动有关的现金194,823,286.4787,425,176.81384,835,951.13297,839,578.93
  经营活动现金流出小计1,001,200,357.9489,374,155.872,224,018,770.951,681,369,859.76
  经营活动产生的现金流量净额259,387,492.47148,197,672.57602,332,501.19310,378,651.88
二、投资活动产生的现金流量:
  收回投资收到的现金61,192,6403,000,000175,254,055.68125,152,028.43
  取得投资收益收到的现金51,340,930.25208,064.09146,102.110,495,787.02
  处置固定资产、无形资产和其他长期资产收回的现金净额26,637,402.821,753,10027,671,230.411,624,945.64
  处置子公司及其他营业单位收到的现金净额0--5,639,381.18
  收到的其他与投资活动有关的现金03,092,640--
  投资活动现金流入小计139,170,973.078,053,804.09203,071,388.18152,912,142.27
  购建固定资产、无形资产和其他长期资产支付的现金234,450,522.47125,270,799.55749,069,810.41535,394,934.85
  投资支付的现金42,015,534.79-152,580,000102,000,000
  取得子公司及其他营业单位支付的现金0---
  支付其他与投资活动有关的现金--24,006,642.93-
  投资活动现金流出小计276,466,057.26125,270,799.55925,656,453.34637,394,934.85
  投资活动产生的现金流量净额-137,295,084.19-117,216,995.46-722,585,065.16-484,482,792.58
三、筹资活动产生的现金流量:
  吸收投资收到的现金0---
  其中:子公司吸收少数股东投资收到的现金0---
  取得借款收到的现金347,013,957.27227,704,235.03817,636,648.58830,309,635.83
  收到其他与筹资活动有关的现金0---
  筹资活动现金流入小计347,013,957.27227,704,235.03817,636,648.58830,309,635.83
  偿还债务支付的现金341,731,733.54193,345,870.58490,939,615.09457,821,179.34
  分配股利、利润或偿付利息支付的现金13,600,428.16,600,355.03147,484,817.24138,637,119.42
  其中:子公司支付给少数股东的股利、利润0-63,744,802.3259,544,802.32
  支付其他与筹资活动有关的现金2,010,788.82804,223.9836,821,019.3932,087,912.36
  筹资活动现金流出小计357,342,950.46200,750,449.59675,245,451.72628,546,211.12
  筹资活动产生的现金流量净额-10,328,993.1926,953,785.44142,391,196.86201,763,424.71
四、汇率变动对现金及现金等价物的影响-9,855,540.66-4,716,771.61-3,830,668.28-1,717,889.33
五、现金及现金等价物净增加额101,907,874.4353,217,690.9418,307,964.6125,941,394.68
  加:期初现金及现金等价物余额659,411,704.58659,411,704.58641,103,739.97641,103,739.97
  期末现金及现金等价物余额761,319,579.01712,629,395.52659,411,704.58667,045,134.65
补充资料:
  净利润29,611,877.51--41,494,108.29-
  资产减值准备20,115,765.82-81,309,947.29-
  固定资产和投资性房地产折旧191,322,200.68-303,305,927.1-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧191,322,200.68-303,305,927.1-
  无形资产摊销29,662,971.29-53,905,825.7-
  长期待摊费用摊销496,574.93-2,136,032.71-
  处置固定资产、无形资产和其他长期资产的损失-1,902,756.57-2,310,905.07-
  固定资产报废损失1,693,609.11-31,151,475.12-
  公允价值变动损失310,556.36-12,021,028.28-
  财务费用23,264,852.65-25,520,605.88-
  投资损失-833,811.77-267,435.35-
  递延所得税17,948,536.14--98,968,994.1-
  其中:递延所得税资产减少16,769,643.16--45,750,416.51-
    递延所得税负债增加1,178,892.98--53,218,577.59-
  存货的减少1,397,502.54-28,389,817.93-
  经营性应收项目的减少32,026,059.68-202,625,350.31-
  经营性应付项目的增加-88,089,668.26--11,725,105.15-
  现金的期末余额761,319,579.01-659,411,704.58-
  减:现金的期初余额659,411,704.58-641,103,739.97-
  现金及现金等价物的净增加额101,907,874.43-18,307,964.61-
公告日期2026-07-312026-04-292026-04-292025-10-25
审计意见(境内)标准无保留意见
TOP↑